FDA Webcast to report Investigation 'Ranitidine converts to a probable carcinogen in Human?'

Next October 14th, 2021 @ 12pm ET FDA will host the webcast ‘Laboratory and Clinical Studies to Investigate Whether Ranitidine Converts to a Probable Carcinogen in Humans’

Researchers at the Center for Drug Evaluation and Research (CDER) conducted and published clinical and nonclinical studies in response to concerns whether ranitidine converts to the probable human carcinogen N-nitrosodimethylamine (NDMA) in humans. This research found no evidence of elevated NDMA content in urine or blood when participants consumed ranitidine and showed that ranitidine does not convert to NDMA in vitro studies under physiologic gastric nitrite concentrations.

To Register

Webcast Registration: *All participants MUST register for webcast to view FDA Grand Rounds!
Webcast Registration Link

Event Information:

Stay Tune for discussion here in Nitrosamine Exchange after the event.

@trust_user_a @trust_user_b



No me puedo registrar

I sent you the link to the FDA website, where a registration button is to do so. Thx

I have been advised that an excipient representative was reported as having posted unsuitable comments in reply to my posting about nitrites in excipients. I wish to advise that there was nothing offensive nor inappropriate in her postings. They were fair comment reflecting the current situation and I cannot for the life of me understand why anyone should have complained.
If we are going to have unmerited censorship on this site then its value will be greatly diminished.

Enclosed is the link to the recording of this session